Firstly, the humanization of mice with human CD34+ cord blood cells or human CD14+ monocytes sets up an “allogeneic” context for the transplanted patient-derived CLL cells, on top of the xenogeneic context already provided in the recipient mice. Here, CD14 is linked to B-cell chronic lymphocytic leukemia.